NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 389 filers reported holding NOVAVAX INC in Q1 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,996,374 | +156.1% | 966,350 | +162.8% | 2.70% | +173.6% |
Q2 2023 | $2,732,383 | +65.8% | 367,750 | +54.7% | 0.99% | +65.7% |
Q1 2023 | $1,647,608 | +900.1% | 237,750 | +1383.6% | 0.60% | +859.7% |
Q4 2022 | $164,737 | -43.6% | 16,025 | 0.0% | 0.06% | -49.6% |
Q3 2022 | $292,000 | -64.6% | 16,025 | 0.0% | 0.12% | -62.2% |
Q2 2022 | $824,000 | -30.2% | 16,025 | 0.0% | 0.32% | -18.3% |
Q1 2022 | $1,180,000 | -50.1% | 16,025 | -3.0% | 0.40% | -49.6% |
Q4 2021 | $2,364,000 | -38.4% | 16,525 | -10.8% | 0.79% | -39.7% |
Q3 2021 | $3,840,000 | -2.4% | 18,525 | 0.0% | 1.31% | +1.4% |
Q2 2021 | $3,933,000 | -7.8% | 18,525 | -21.3% | 1.29% | -14.0% |
Q1 2021 | $4,265,000 | -23.6% | 23,525 | -53.0% | 1.50% | -24.2% |
Q4 2020 | $5,584,000 | -14.2% | 50,075 | -16.6% | 1.98% | -25.5% |
Q3 2020 | $6,509,000 | +7.6% | 60,075 | -17.2% | 2.66% | +3.1% |
Q2 2020 | $6,049,000 | +217.5% | 72,575 | -48.3% | 2.58% | +139.9% |
Q1 2020 | $1,905,000 | +282.5% | 140,250 | +12.2% | 1.08% | +408.0% |
Q4 2019 | $498,000 | – | 125,000 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |